11
Summary risk of incident AF Effect of LRFM
risk
N/A
• Hypertension: risk
• SBP: risk
• DBP: risk
• Renal denervation: AF postablation
• Mineralocorticoid receptor antagonists (MRAs):
AF burden
• BP control postablation:
• Intensive BP control to SBP <120 mm
Hg in patients with HTN at high risk for
cardiovascular disease (CVD): AF risk
• BP control as part of a comprehensive LRFM
program: AF burden
• Slow heart rate: variable
risk
• Higher heart rate: variable
risk
N/A
risk • Optimal glycemic control preablation may AF
recurrence postablation
